Sodexo: JPMorgan upgrades as turnaround thesis gains traction — but the October earnings test is imminent

On September 17, JPMorgan analyst Estelle Weingrod upgraded Sodexo from Neutral to Overweight, raising her price target to 68 euros from 54 euros. The stock was already near a 15-month high of 59 euros. The upgrade didn't create the rally. It validated a thesis that has been building for months: that a new CEO, a published turnaround plan, a major client win, and a quarter of accelerating growth are enough to convince the market that Sodexo's worst chapter is behind it.

The question for anyone watching from the sidelines is whether this is a conviction moment or a trap at the top of a recovery that hasn't proved itself yet.

How the stock got here

Sodexo — the French food services and facilities management giant that runs cafeterias and workplace services for corporations worldwide — spent the first half of fiscal 2026 bleeding credibility.

In the first half of FY2026, organic revenue growth came in at just 1.7%. Underlying operating profit margin fell 140 basis points to 3.7%, down from 4.7% a year earlier. Management cited execution challenges and initial restructuring costs. Sodexo cut its full-year guidance, projecting organic growth between 0.5% and 1%, and margins between 3.2% and 3.4%.

Credit agencies sounded the alarm. Fitch revised the outlook to negative in May. S&P downgraded the company from BBB+ to BBB in July, saying Sodexo was unlikely to improve credit metrics to BBB+ levels within 18 to 24 months. S&P forecast adjusted EBITDA margins declining from 6.3% in FY2025 to 4.3% in FY2026.

The stock bottomed around 36 euros, trading at roughly 9 times earnings — about one-third the valuation of peers Compass Group and Aramark. At that point, Sodexo looked like a classic deep-value case: a 6% dividend yield, a market leader in a stable industry, and a stock priced as if it were going out of business. The market was separating the company from the stock.

The turning point

Three things changed in quick succession.

First, Sodexo brought in Thierry Delaporte as CEO in October 2025 — its first external hire in the role. Jefferies called it a "tipping point" for a multi-year turnaround and upgraded the stock in March, raising its price target from 41 to 55 euros.

Second, in July, Delaporte unveiled "Shift & Grow 2030," a published plan with specific numbers. The roadmap has two phases. Through fiscal 2027, Sodexo will focus on rebuilding competitiveness and absorbing higher investment. From 2028 onward, the goal is acceleration. By fiscal 2030, management targets organic revenue growth above 5% and underlying operating margins above 5% — a return to the profitability range it held before the compression. For FY2027 specifically, management expects 2% to 3% organic growth with margins still at 3.2% to 3.4%, meaning the company is willing to invest before it extracts margin expansion.

Third, on the same day as the plan launch, Sodexo announced a global food services contract with Meta covering more than 130 locations across 30 countries. It was one of the largest standalone workplace food services deals the company has won. That matters in a business where the single biggest question is always whether your commercial team is winning.

And then came the operational proof. In Q3 of FY2026, organic revenue growth accelerated to 2.0%, above expectations. Sodexo raised its full-year organic growth guidance to between 1.2% and 1.5%, while maintaining the margin outlook.

Where valuation stands now

Here's where the picture gets harder.

The stock has risen well over 50% from its April lows. It was trading near 59 euros before the JPMorgan upgrade — not far from Barclays' equalweight target of 54 euros or Citi's hold-rated target of 60 euros. JPMorgan's 68-euro price target implies roughly 10% more upside from current levels, but getting to that target requires the market to keep rewarding a story that hasn't completed its proof yet.

The margin problem is the most visible reason Sodexo was cheap, and the most visible reason the market is skeptical. Underlying operating margins fell from 4.7% in FY2025 to roughly 3.7% in H1 FY2026. Management guidance keeps the full-year target at 3.2% to 3.4%. Even by FY2027, Sodexo isn't promising any meaningful margin recovery — the plan explicitly absorbs the investment before seeking expansion. That means two more full fiscal years of thin margins before the company claims it's turning the corner.

Meanwhile, credit agencies remain cautious. S&P's downgrade to BBB in July reflected a view that EBITDA margins will compress and stay compressed for a while. Fitch's negative outlook from May says the same thing from a different angle. Credit raters don't care about stock price momentum. They care about whether the company can service its debt while margins are thin.

The 6% dividend yield that made Sodexo attractive at 36 euros has compressed sharply as the stock has risen. For investors who came in for the yield, the math has changed. The yield may still be there — if cash flow supports it — but the cushion has narrowed.

The October test

Sodexo reports its full-year fiscal 2026 results on October 23. That's less than four weeks away.

This is the first earnings report where the market will judge Delaporte's plan, the Meta contract, and the Q3 growth acceleration as a complete story. If full-year organic growth lands at the top end of the 1.2% to 1.5% guidance range, and if management can show that margin investment is deliberate and time-bound, the stock could sustain its higher levels. The narrative would hold: the market was right to separate the business quality from the temporary execution problems.

If growth comes in at the bottom of the range, or if margins fall below 3.2%, the upgrade's thesis loses its foundation. The stock would be sitting near a 15-month high on a turnaround that still hasn't delivered on margins, with credit agencies watching skeptically and the company itself admitting that real margin recovery won't arrive until 2028 at the earliest.

There's also the peer comparison to keep in mind. Compass Group and Aramark trade at multiples roughly three times Sodexo's. Sodexo's discount was the entire reason the stock looked cheap in April. If the discount narrows — as it has — the turnaround needs to produce more than incrementalism to justify the higher multiple.

What to make of it

JPMorgan's upgrade is a reasonable call on the direction of the story. Delaporte is a credible hire. The Shift & Grow 2030 plan has specific, measurable targets that can be tracked. The Meta contract is real business, not a press release. And Q3 growth did accelerate.

But the stock has moved faster than the operating proof. The margin trajectory remains the central risk — margins fell, the plan accepts another year of thin margins, and credit agencies don't expect recovery before 2027 at the earliest. A 10% implied upside from JPMorgan's target doesn't leave much room for the kind of execution risk that a turnaround in progress carries.

The investor takeaway isn't about whether Sodexo will turn around. The more useful question is whether the stock has priced that turn already. At near 59 euros, with October 23's results just around the corner, the market is asking investors to bet on acceleration before the company has proven it can deliver it. That's not a reason to short the stock, but it is a reason to wait for the October print before committing.